Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system

Qing An,1,* Yingxin Zheng,2,3,* Yirong Zhao,2,* Tao Liu,2 Huaizu Guo,2 Dapeng Zhang,2–4 Weizhu Qian,5 Hao Wang,5 Yajun Guo,2,4,6,7 Sheng Hou,2,4 Jing Li2,81Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer...

Full description

Bibliographic Details
Main Authors: An Q, Zheng Y, Zhao Y, Liu T, Guo H, Zhang D, Qian W, Wang H, Guo Y, Hou S, Li J
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Drug Design, Development and Therapy
Subjects:
Infliximab
Biosimilar
Biobetter
CMAB008
Immunogenicity.
Online Access:https://www.dovepress.com/physicochemical-characterization-and-phase-i-study-of-cmab008-an-infli-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/physicochemical-characterization-and-phase-i-study-of-cmab008-an-infli-peer-reviewed-article-DDDT

Similar Items